← Back
Data updated: Mar 10, 2026
MEDIMETRIKS PHARMS
Infectious DiseaseDermatology
MEDIMETRIKS PHARMS is a major pharmaceutical company focused on Infectious Disease, Dermatology. Key products include VANCOMYCIN HYDROCHLORIDE.
1963
Since
7
Drugs
-
Trials
34
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-01-30
Labeling
AMPICILLIN AND SULBACTAM 2026-01-27
Labeling
AMPICILLIN AND SULBACTAM 2026-01-19
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 60%
3 drugs
Dermatology 40%
2 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 1963-02-15
- Latest
- 2025-11-04
- Applications
- 10